Qingdao Baheal Medical Inc. (referred to as “Baheal Medical”, Stock Code: 301015) was founded in 2005. As A-share leading health brand commercialization platform, Baheal Medical focuses on the brand operation and building of global high-quality medical and health products, effectively optimizes the medical scenarios through technological innovation.

Through our core capabilities in category insight and brand operation, digital marketing and ecological organization collaboration, we spare no effort in building “brand highways” and providing upstream industrial enterprises with omni-channel commercialization solutions that improve the operational efficiency and promote the standardized development of the industry. Through more than ten years of unremitting efforts, we have established a strong marketing network while cooperating with more than 14,000 large and medium-sized hospitals, and nearly 400,000 pharmacies. Our product matrix covers four major categories: Over-the-counter (OTC) and healthcare, OTX and prescription drug, oncology drugs, as well as high-end medical devices. Additionally, Baheal Medical has forged stable partnerships with hundreds of upstream enterprises, in addition to incubating multiple leading brands.